个性化文献订阅>期刊> Current Pharmaceutical Design
 

New Insight Into A(1) Adenosine Receptors in Diabetes Treatment

  作者 Wojcik, M; Zieleniak, A; Wozniak, LA  
  选自 期刊  Current Pharmaceutical Design;  卷期  2010年16-38;  页码  4237-4242  
  关联知识点  
 

[摘要]The A(1) adenosine receptors (A(1)AR), belonging to the rhodopsin-like superfamily of the G-protein-coupled receptors (GPCRs), may regulate many various cellular processes in cardiovascular, renal, and central nervous systems. In addition, since the A(1)AR possesses antilipolytic properties, numerous A(1)AR agonists and antagonists have been developed, but only some of them with the most promising selective properties in vitro have been advanced to animal studies and clinical trials. In this review, we have summarized the studies on the utility of A(1)AR selective agonists and antagonists in the regulation of lipid and carbohydrate metabolism and their potential therapeutic applications in diabetes.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内